Complement-targeted therapies in kidney transplantation-insights from preclinical studies.
Complement-targeted therapies in kidney transplantation-insights from preclinical studies.
复制标题
DOI:
10.3389/fimmu.2022.984090
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
Kwun, Jean
中科院分区:
文献类型:
--
作者:
Anwar, Imran J.;DeLaura, Isabel;Ladowski, Joseph;Gao, Qimeng;Knechtle, Stuart J.;Kwun, Jean
Aberrant activation of the complement system contributes to solid-organ graft dysfunction and failure. In kidney transplantation, the complement system is implicated in the pathogenesis of antibody- and cell-mediated rejection, ischemia-reperfusion injury, and vascular injury. This has led to the evaluation of select complement inhibitors (e.g., C1 and C5 inhibitors) in clinical trials with mixed results. However, the complement system is highly complex: it is composed of more than 50 fluid-phase and surface-bound elements, including several complement-activated receptors—all potential therapeutic targets in kidney transplantation. Generation of targeted pharmaceuticals and use of gene editing tools have led to an improved understanding of the intricacies of the complement system in allo- and xeno-transplantation. This review summarizes our current knowledge of the role of the complement system as it relates to rejection in kidney transplantation, specifically reviewing evidence gained from pre-clinical models (rodent and nonhuman primate) that may potentially be translated to clinical trials.
登录
查看更多内容
影响因子:
5.4
作者:
DANIELSSON, C;PASCUAL, M;SCHIFFERLI, JA
通讯作者:
SCHIFFERLI, JA
影响因子:
8.8
作者:
Eskandary, F.;Jilma, B.;Boehmig, G. A.
通讯作者:
Boehmig, G. A.
DOI:
10.1007/978-1-4614-4118-2_4
发表时间:
2013-01-01
期刊:
COMPLEMENT THERAPEUTICS
影响因子:
--
作者:
Das, Nibhriti;Biswas, Bintili;Khera, Rohan
通讯作者:
Khera, Rohan
影响因子:
20.1
作者:
Brunn, GJ;Saadi, S;Platt, JL
通讯作者:
Platt, JL
影响因子:
3.9
作者:
Estrada JL;Martens G;Li P;Adams A;Newell KA;Ford ML;Butler JR;Sidner R;Tector M;Tector J
通讯作者:
Tector J